IPH4102/Lacutamab Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma

NCT03902184 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, T-Cell
Lymphoma, T-Cell, Cutaneous
Mycosis Fungoides/Sezary Syndrome

Interventions

BIOLOGICAL: IPH4102

Sponsor

Innate Pharma